Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$0.7 - $1.51 $154 - $332
-220 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$1.16 - $2.23 $197 - $379
170 Added 340.0%
220 $1,000
Q4 2021

Jan 14, 2022

SELL
$1.16 - $2.23 $197 - $379
-170 Reduced 77.27%
50 $1,000
Q3 2020

Oct 21, 2020

BUY
$4.11 - $6.45 $904 - $1,419
220 New
220 $1,000

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.